FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nafsika Georgopapadakou

Research Profile

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Henk J Broxterman; Nafsika H Georgopapadakou
Anticancer therapeutics: a surge of new developments increasingly target tumor and stroma.
Henk J Broxterman; Nafsika H Georgopapadakou
Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations.
Nafsika H Georgopapadakou
Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nafsika Georgopapadakou (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Henk J Broxterman; Nafsika H Georgopapadakou
Anticancer therapeutics: a surge of new developments increasingly target tumor and stroma.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007;10(4-5):182-93.
2005: Henk J Broxterman; Nafsika H Georgopapadakou
Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2005;8(4):183-97.
2004: Nafsika H Georgopapadakou
Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.
Expert opinion on investigational drugs 2004;13(10):1307-18.
2004: Henk J Broxterman; Nafsika H Georgopapadakou
New cancer therapeutics: target-specific in, cytotoxics out?
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2004;7(2):79-87.
2004: Geoffrey Stone; Qin Zhang; Rosario Castillo; Venkata Ramana Doppalapudi; Analia R Bueno; Jean Y Lee; Qing Li; Maria Sergeeva; Gody Khambatta; Nafsika H Georgopapadakou
Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.
Antimicrobial agents and chemotherapy 2004;48(2):477-83.
2002: Nafsika H Georgopapadakou
Infectious disease 2001: drug resistance, new drugs.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2002;5(5):181-91.
2002: Nafsika H Georgopapadakou
Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.
Expert opinion on investigational drugs 2002;11(8):1117-25.
2002: Nafsika H Georgopapadakou
A diversity of therapeutic targets.
Expert opinion on therapeutic targets 2002;6(3):255-6.
2002: Cynthia R Pennise; Nafsika H Georgopapadakou; R Dale Collins; Nilsa R Graciani; David L Pompliano
A continuous fluorometric assay of myristoyl-coenzyme A:protein N-myristoyltransferase.
Analytical biochemistry 2002;300(2):275-7.
2001: Henk J Broxterman; Nafsika H Georgopapadakou
Cancer research 2001: drug resistance, new targets and drug combinations.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2001;4(3):197-209.